nsNSAIDs

DRUG2 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Organon and Co

Conditions

Arthritis, Juvenile RheumatoidSpondylarthropathies; Spondylitis, Ankylosing

Unknown Phase

Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis

TerminatedNCT00688545

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Arthritis, Juvenile Rheumatoid

Start: 2009-04-30End: 2012-01-31Updated: 2021-02-02

Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)

CompletedNCT01327638

Organon and CoSpondylarthropathies; Spondylitis, Ankylosing

Start: 2011-02-15End: 2018-12-06Updated: 2024-05-10

Related Papers

Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the phase 4 registry

Pediatric Rheumatology2014-07-1630 citations